EGFR-IN-57

Modify Date: 2025-08-22 23:24:48

EGFR-IN-57 Structure
EGFR-IN-57 structure
Common Name EGFR-IN-57
CAS Number 2492382-37-1 Molecular Weight 385.44
Density N/A Boiling Point N/A
Molecular Formula C22H15N3O2S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of EGFR-IN-57


EGFR-IN-57 (Compound 25a) is a potent, orally active EGFR-TK inhibitor with an IC50 of 0.054 µM. EGFR-IN-57 also inhibits VEGFR-2, CK2α, topoisomerase IIβ and tubulin polymerization with IC50 values of 0.087, 0.171, 0.13 and 3.61 µM, respectively. EGFR-IN-57 induces cell cycle arrest at G2/M and pre-G1 phases. EGFR-IN-57 induces cancer cell apoptosis[1].

 Names

Name EGFR-IN-57

 EGFR-IN-57 Biological Activity

Description EGFR-IN-57 (Compound 25a) is a potent, orally active EGFR-TK inhibitor with an IC50 of 0.054 µM. EGFR-IN-57 also inhibits VEGFR-2, CK2α, topoisomerase IIβ and tubulin polymerization with IC50 values of 0.087, 0.171, 0.13 and 3.61 µM, respectively. EGFR-IN-57 induces cell cycle arrest at G2/M and pre-G1 phases. EGFR-IN-57 induces cancer cell apoptosis[1].
Related Catalog
Target

EGFR:0.054 μM (IC50)

VEGFR-2:0.087 μM (IC50)

CK2α:0.171 μM (IC50)

topoisomerase II beta:0.13 μM (IC50)

tubulin polymerization:3.16 μM (IC50)

References

[1]. Warda ET, et al. New series of isoxazole derivatives targeting EGFR-TK: Synthesis, molecular modeling and antitumor evaluation. Bioorg Med Chem. 2020 Nov 1;28(21):115674.

 Chemical & Physical Properties

Molecular Formula C22H15N3O2S
Molecular Weight 385.44
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.